Oncotype DX vs Freenome

Side-by-side comparison of cancer screening tests.

← Back to Cancer Screening

Oncotype DX

Guideline recommended
Variable

Breast recurrence risk

Freenome

In development
Variable

Multiple

Test Performance

FeatureOncotype DXFreenome
PriceVariableVariable
Cancers DetectedBreast recurrence riskMultiple
SensitivityN/ANot disclosed
SpecificityN/ANot disclosed
Sample TypeTumor tissueBlood draw
FDA StatusGuideline recommendedIn development